By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


INSYS Therapeutics 

10220 South 51st Street
Suite 2
Phoenix  Arizona  85044  U.S.A.
Phone: 602-910-2617 Fax: 602-910-2627


Company News
INSYS Therapeutics Intends to Spend $100 Million on Drug Projects in 2016 11/24/2015 5:54:35 AM
INSYS Therapeutics CEO Steps Down, New Leader Appointed 11/5/2015 6:20:47 AM
INSYS Therapeutics Announces Its Naloxone Sublingual Spray Received Fast Track Designation From FDA For The Treatment Of Opioid Intoxication Or Overdose 10/30/2015 12:45:50 PM
INSYS Therapeutics Issues Statement On Its Use Of Specialty Pharmacies 10/27/2015 12:58:11 PM
INSYS Therapeutics To Report Third Quarter 2015 Results 10/22/2015 4:14:07 PM
INSYS Therapeutics In-Licenses Cannabinoid Inhalation Technology 9/28/2015 1:08:19 PM
INSYS Therapeutics To Present At 10th Annual Wells Fargo Healthcare Conference 9/3/2015 11:40:42 AM
INSYS Therapeutics Files Citizen Petition With The Drug Enforcement Administration (DEA) To Reschedule Its Synthetic Pharmaceutical Cannabidiol (CBD) 8/19/2015 1:47:09 PM
INSYS Therapeutics' Dronabinol Oral Solution NDA Accepted For Filing By FDA 8/17/2015 10:48:07 AM
INSYS Therapeutics Reports Second Quarter 2015 Results 8/7/2015 9:13:58 AM